[Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007741:Labetalol / Q000627:therapeutic use*; D010096:Oxprenolol / Q000627:therapeutic use; D012083:Renin / Q000097:blood
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D004983:Ethanolamines; D010096:Oxprenolol; D012083:Renin; D007741:Labetalol
Kombinierte Alpha- und Beta-Adrenoceptorblockade in der Behandlung der renalen Hypertonie.